Xenetic Biosciences Inc share price logo

Xenetic Biosciences Inc Share Price

NASDAQ: XBIO

Small Cap

$3.06

+0.25

(+8.69%)

as on

Xenetic Biosciences Inc Stock Performance

as on April 3, 2026 at 6:59 am IST

  • Day's Low

    $2.70
    $3.06
    downward going graph

    11.76%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.90
    $13.93
    downward going graph

    37.91%

    Downside

    355.23%

    Upside

    downward going graph

Xenetic Biosciences Inc share price movements today

Previous Close
$2.82
Open
$2.79
Volume
320.8K
Day's Low - High
$2.70 - $3.06
52 Week Low - High
$1.90 - $13.93

Xenetic Biosciences Inc Historical Returns

1 Month Return
+ 31.44 %
3 Month Return
+ 42.38 %
1 Year Return
+ 22.11 %
3 Year Return
-30 %
5 Year Return
-85.73 %

Xenetic Biosciences Inc Stock Fundamentals & Key Indicators

Check Xenetic Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.9M

EPS (TTM)

-3.32

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-5.7M

Revenue (TTM)

3.0M

Profit Margin

-90.07%

Return On Equity TTM

-40.00%

Xenetic Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xenetic Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Xenetic Biosciences Inc image
Xenetic Biosciences Inc
SELL$6.9M-85.73%NA-90.07%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B124.53%136.858.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.4B103.77%28.6632.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.7BNA126.855.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.5B59.16%18.3831.41%

Stock Returns calculator for Xenetic Biosciences Inc Stock including INR - Dollar returns

The Xenetic Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Xenetic Biosciences Inc investment value today

Current value as on today

₹1,34,223

Returns

₹34,223

(+34.22%)

Returns from Xenetic Biosciences Inc Stock

₹24,390 (+24.39%)

Dollar Impact

₹9,832 (+9.83%)

Analyst Recommendation on Xenetic Biosciences Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Xenetic Biosciences Inc. Average target price of $40

Xenetic Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Xenetic Biosciences Inc.

What analysts predicted

92.35%UPSIDE

Target Price

$40

Current Price

$3.06

Analyzed by

6 Analysts

Target

$40.00

Xenetic Biosciences Inc target price $40, a slight upside of 92.35% compared to current price of $3.06. According to 6 analysts rating.

Xenetic Biosciences Inc Stock’s Investor Sentiment and Interest

Search interest for Xenetic Biosciences Inc Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:13% versus previous 30 day period

Xenetic Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
0
0
1
0
Gross Profit
0
0
0
0
0
0
0
0
1
0
Operating Income
-1
-1
-1
-1
0
-1
0
0
0
0
EBITDA
-1
-1
-1
-1
0
-1
0
0
0
0
Interest Expense
-
0
0
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-1
-1
-1
-1
0
-1
0
0
0
0
Income Tax Expense
0
0
0
0
0
-
0
-
-
-
Net Income
-1
-1
-1
-1
0
-1
0
0
0
0
Net Profit Margin
-172.71%
-174.34%
-233.96%
-175.38%
-71.09%
-162.53%
-152.23%
-116.75%
-49.66%
-75.57%

Xenetic Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
3
7
-
0
0
1
1
2
2
2
Gross Profit
2
7
0
0
0
1
1
2
2
2
Operating Income
-47
-3
-7
-12
-13
-5
-6
-4
-4
-2
EBITDA
-53
-3
-7
-9
-4
-5
-6
-4
-4
-2
Interest Expense
0
0
0
0
18
0
0
-
-
-
Depreciation
-
0
0
0
0
0
0
-
-
-
Income Before Tax
-54
-3
-7
-12
-13
-5
-6
-4
-3
-2
Income Tax Expense
6
0
0
3
-2
0
0
0
-
-
Net Income
-54
-3
-7
-12
-10
-5
-6
-4
-3
-2
Net Profit Margin
-1806.87%
-47.40%
0.00%
-74856.59%
-2493.11%
-486.36%
-383.87%
-162.78%
-158.39%
-90.07%

Xenetic Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-1
-1
-1
0
-1
0
0
0
0
Operating Cash Flow
0
-1
0
0
0
-1
0
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
4
Change in Cash
0
-1
0
0
0
-1
0
0
3

Xenetic Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-3
-7
-12
-10
-5
-6
-4
-3
-2
Operating Cash Flow
1
-6
-6
-4
-4
-4
-4
-2
-2
Investing Cash Flow
0
0
0
-
-
0
-
-
-
Financing Cash Flow
0
1
16
5
11
1
0
0
4
Change in Cash
1
-4
9
1
6
-5
-4
-2
1

Global Institutional Holdings in Xenetic Biosciences Inc

Funds
Holdings
SBI Securities Co Ltd
0%
Geode Capital Management, LLC
0.47%
Geode Capital Management, LLC
0.59%
Sachetta LLC
0.67%
Harwood Advisory Group, LLC
0%
See all

Insights on Xenetic Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, XBIO stock has moved up by 12.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 51.1% return, outperforming this stock by 81.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.3% return, outperforming this stock by 13.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.02M → 766.29K (in $), with an average decrease of 25.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -509.93K → -579.07K (in $), with an average decrease of 13.6% per quarter

About Xenetic Biosciences Inc

xenetic biosciences (nasdaq: xbio) is a clinical-stage biopharmaceutical company focused on discovery, research and development of next-generation biologic drugs and novel oncology therapeutics. xenetic's proprietary drug development platforms include polyxen™, which enables next generation biologic drugs by improving their half-life and other pharmacological properties. xenetic's lead investigational product candidates include fda orphan designated oncology therapeutic sodium cridanimod for the treatment of progesterone receptor negative endometrial cancer, and a polysialylated form of erythropoietin for the treatment of anemia in pre-dialysis patients with chronic kidney disease. xenetic is also working together with shire plc (formerly baxalta, baxter incorporated and baxter healthcare) to develop a novel series of polysialylated blood coagulation factors, including a next generation factor viii. this collaboration relies on xenetic's polyxen technology to conjugate polysialic acid
OrganisationXenetic Biosciences Inc
Headquarters945 Concord Street, Framingham, MA, United States, 01701
IndustryHealth Technology
CEOMr. James F. Parslow
E-voting on sharesClick here to vote

Key Management of Xenetic Biosciences Inc

Name

Title

Mr. James F. Parslow

CFO, COO, Interim CEO & Corporate Secretary

FAQs

What is Xenetic Biosciences Inc share price today?

Xenetic Biosciences Inc share price today is $3.06 as on at the close of the market. Xenetic Biosciences Inc share today touched a day high of $3.06 and a low of $2.7.

What is the 52 week high and 52 week low for Xenetic Biosciences Inc share?

Xenetic Biosciences Inc share touched a 52 week high of $13.93 on and a 52 week low of $1.9 on . Xenetic Biosciences Inc stock price today i.e. is closed at $3.06,which is 78.03% down from its 52 week high and 61.05% up from its 52 week low.

What is Xenetic Biosciences Inc's market capitalisation today?

Xenetic Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Xenetic Biosciences Inc Stock (XBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xenetic Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xenetic Biosciences Inc Shares that will get you 0.4902 shares as per Xenetic Biosciences Inc share price of $3.06 per share as on April 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Xenetic Biosciences Inc Stock (XBIO) from India?

Indian investors can start investing in Xenetic Biosciences Inc (XBIO) shares with as little as ₹92.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Xenetic Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Xenetic Biosciences Inc share’s latest price of $3.06 as on April 3, 2026 at 1:29 am IST, you will get 3.2680 shares of Xenetic Biosciences Inc. Learn more about fractional shares .

What are the returns that Xenetic Biosciences Inc has given to Indian investors in the last 5 years?

Xenetic Biosciences Inc stock has given -85.73% share price returns and 26.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?